tiprankstipranks
Advertisement
Advertisement

NTRA Stock Latest News

Natera initiated with an Outperform at William Blair
The FlyNatera initiated with an Outperform at William Blair
3d ago
NTRA
Natera: Premium-Valued Leader in MRD Positioned for Long-Term Growth and Margin Expansion
PremiumRatings
Natera: Premium-Valued Leader in MRD Positioned for Long-Term Growth and Margin Expansion
4d ago
NTRA
Natera highlights Allogene Therapeutics’ analysis from ALPHA3 trial
PremiumThe Fly
Natera highlights Allogene Therapeutics’ analysis from ALPHA3 trial
4d ago
ALLO
NTRA
Natera awarded 30% ongoing royalty for MRD-related patents
PremiumThe Fly
Natera awarded 30% ongoing royalty for MRD-related patents
8d ago
NTRA
Citi opens ‘upside 90-day catalyst watch’ on Natera
PremiumThe Fly
Citi opens ‘upside 90-day catalyst watch’ on Natera
10d ago
NTRA
Natera price target lowered to $250 from $260 at Evercore ISI
PremiumThe FlyNatera price target lowered to $250 from $260 at Evercore ISI
11d ago
NTRA
Natera Expands Board, Appoints Eric Rubin as Director
Premium
Company Announcements
Natera Expands Board, Appoints Eric Rubin as Director
16d ago
8K
NTRA
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
Premium
Market News
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
29d ago
BSX
IHE
Natera announces publications on clinical utility of Signatera
PremiumThe Fly
Natera announces publications on clinical utility of Signatera
1M ago
NTRA
GeneDx data could support improved coverage, says Craig-Hallum
PremiumThe Fly
GeneDx data could support improved coverage, says Craig-Hallum
1M ago
WGS
NTRA
Natera announces commercial launch of Zenith genomics
PremiumThe Fly
Natera announces commercial launch of Zenith genomics
1M ago
WGS
NTRA
GeneDx falls after Natera launches sequencing assay for rare diseases
PremiumThe Fly
GeneDx falls after Natera launches sequencing assay for rare diseases
1M ago
WGS
NTRA
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Portfolio Diversification to Investors
PremiumMarket NewsIHI, IHE, ARKG: Specialty Healthcare ETFs Offer Portfolio Diversification to Investors
1M ago
BSX
IHE
Natera Inc. Earnings Call Signals Profitable Growth
Premium
Company Announcements
Natera Inc. Earnings Call Signals Profitable Growth
1M ago
NTRA
Natera price target lowered to $250 from $265 at Morgan Stanley
Premium
The Fly
Natera price target lowered to $250 from $265 at Morgan Stanley
2M ago
NTRA
Maintained Buy on Natera: DCF‑Backed Upside and Attractive Long‑Term Growth Profile Despite Lower Price Target
PremiumRatings
Maintained Buy on Natera: DCF‑Backed Upside and Attractive Long‑Term Growth Profile Despite Lower Price Target
2M ago
NTRA
Natera: Strong Execution, Growing Signatera MRD Franchise, and Multiple Catalysts Support Buy Rating and $260 Target
PremiumRatings
Natera: Strong Execution, Growing Signatera MRD Franchise, and Multiple Catalysts Support Buy Rating and $260 Target
2M ago
NTRA
Natera: Sustained Outperformance, Conservative 2026 Guidance, and Innovation-Driven Upside Support Buy Rating and $285 Target
PremiumRatings
Natera: Sustained Outperformance, Conservative 2026 Guidance, and Innovation-Driven Upside Support Buy Rating and $285 Target
2M ago
NTRA
Natera to present new data in geniturinary malignancies at ASCO GU
PremiumThe Fly
Natera to present new data in geniturinary malignancies at ASCO GU
2M ago
NTRA
Natera price target raised to $260 from $250 at Evercore ISI
PremiumThe FlyNatera price target raised to $260 from $250 at Evercore ISI
2M ago
NTRA
Natera price target raised to $290 from $280 at UBS
Premium
The Fly
Natera price target raised to $290 from $280 at UBS
2M ago
NTRA
Natera price target raised to $215 from $205 at Wells Fargo
Premium
The Fly
Natera price target raised to $215 from $205 at Wells Fargo
2M ago
NTRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >